Explore the pros and cons of managing genetic information via public and proprietary companies. 

Even in the US, some controversy persists over the conceptual defensibility of brain death. Around the world, the philosophical defensibility of brain death is even more debatable. 

James Corbett

Harvard Gazette
By John Laidler, Harvard Correspondent
Shifts in the field can allow providers both to prosper and serve patients better, speaker James Corbett says.

Register now for the Annual Bioethics Conference

This multidisciplinary program was co-sponsored by the Center for Bioethics at Harvard Medical School and 

ALS neuroethics lecture

Patients with ALS have a uniformly fatal disease, and one might worry that ALS patients are even more prone to the therapeutic misconception. In this video, panelists discuss evidence for therapeutic misconception in ALS trials.

Neurologists who treat epilepsy face substantial difficulty distinguishing "true" seizures caused by abnormal electrical discharges from seizures that are caused by psychological factors (psychogenic nonepileptic seizures, or PNES).

A Conversation with Charles Bosk, December 10th at Harvard Medical School

In this candid interview with Christine Mitchell, Executive Director of the Center for Bioethics, Dr. Angell discusses the progress that has been made in medical ethics, and the setbacks that have kept other issues in play.

Michele Bratcher Goodwin

Connecting the human brain to a computer is no longer science fiction. Patients unable to control their bodies will soon be able to control computers and external devices, like wheelchairs, using only mental processes, by means of a brain-computer interface. A Neuroethics Seminar Series Event with Philipp Kellmeyer and Leigh Hochberg